Company intelligence / Profile preview

Indigo Diabetes

Ownership: Private
Development stage: Other

Overview

Indigo Diabetes has developed a fully implantable sensor for continuous multi-metabolite monitoring. The device measures glucose, ketones, and lactate subcutaneously without the need for an external wearable. Initial focus is on diabetes management; broader applications are under consideration. Clinical results have not been published in detail but the company highlights best-in-class data delivery and real-time metabolic trend tracking via a connected app[1][6].

Therapeutic areas: OncologyEndocrinologyOtherCardiovascularNephrology
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Indigo Diabetes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indigo Diabetes.

Explore the full profile